DES MOINES, Iowa (KCCI) – Iowa researchers are working on a new type of coronavirus vaccine that you can smell.
The Nanovaccine Institute at ISU shifted its focus from flu to COVID-19 when the pandemic hit the US
Unlike Pfizer and Moderna, the nanovaccine will have no needle and will require only one dose. It also does not need to be refrigerated.
With the help of $ 2 million in federal funding under the CARES Act, they are collaborating with researchers at other institutions to create the vaccine.
“Our hope is that these clinical trials will begin in the next 12 months and, once these clinical trials are completed, we will be able to have a product,” said Balaji Narasimhan, director of the Nanovaccine Institute.
They said that if everything goes according to plan, the nanovacin will be available in a year and a half.
Pfizer and Moderna are the only COVID-19 vaccines approved in the US so far.
See the article on the KCCI website.
Copyright 2020 KCCI. All rights reserved.